Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amendment : Form 8.3 - Pollen Street Secured Lending Plc

17 Aug 2020 15:42

Metage Capital Limited - Amendment : Form 8.3 - Pollen Street Secured Lending Plc

Metage Capital Limited - Amendment : Form 8.3 - Pollen Street Secured Lending Plc

PR Newswire

London, August 17

AMENDMENT TO FORM 8.3 Submitted at 13:54 on 17TH August 2020 (Change to 1(f))

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Metage Capital Limited
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereePollen Street Secured Lending Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure14/08/20
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES - Honeycomb Investment Trust Plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:1p Ordinary
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:786,3931.067
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 786,393 1.067

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
1p ordinarySale21,1058.072995

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:17/08/20
Contact name:Maryam Valantin
Telephone number*:+44 (0)203 813 8593

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
21st Aug 20177:00 amRNSNet Asset Value - July 2017
21st Aug 20177:00 amRNSMonthly Update - July 2017
18th Aug 20177:00 amRNSHolding(s) in Company - TR-1 Notification
21st Jul 20177:00 amRNSNet Asset Value - June 2017
21st Jul 20177:00 amRNSMonthly Update - June 2017
21st Jun 20177:00 amRNSNet Asset Value(s) - May 2017
21st Jun 20177:00 amRNSMonthly Update - May 2017
5th Jun 201712:48 pmRNSHolding(s) in Company - TR-1 Notification
2nd Jun 20172:15 pmRNSResult of Annual General Meeting
31st May 20174:00 pmRNSResults of Initial Placing
25th May 201712:15 pmRNSPublication of Prospectus and Placing
18th May 20177:00 amRNSNet Asset Value - 30 April 2017
18th May 20177:00 amRNSMonthly Update - April 2017
28th Apr 20175:00 pmRNSNotice of AGM
28th Apr 20175:00 pmRNSAGM and Financial Statement Notification
28th Apr 20177:30 amRNSDividend Declaration - Period to 31 March 2017
28th Apr 20177:00 amRNSAnnual Report and Financial Statements - Dec 2016
25th Apr 201711:23 amRNSMonthly Update - March 2017
25th Apr 20177:00 amRNSNet Asset Value - March 2017
21st Mar 20177:00 amRNSNet Asset Value - February 2017
21st Mar 20177:00 amRNSMonthly Update - February 2017
28th Feb 20179:30 amRNSTransfer of shareholding
28th Feb 20177:00 amRNSDividend Declaration - Period to 31 December 2016
21st Feb 20179:59 amRNSMonthly Update - January 2017
21st Feb 20179:58 amRNSNet Asset Value - January 2017
19th Jan 20172:49 pmRNSMonthly Update - December 2016
19th Jan 20172:12 pmRNSNet Asset Value - December 2016
21st Dec 20164:19 pmRNSMonthly Update - November 2016
20th Dec 20169:41 amRNSHolding(s) in Company - TR-1 Notification
20th Dec 20169:38 amRNSHolding(s) in Company - TR-1 Notification
19th Dec 201610:32 amRNSHolding(s) in Company - TR-1 Notification
16th Dec 20162:57 pmRNSPDMR Shareholding
14th Dec 20167:00 amRNSNet Asset Value - November 2016
12th Dec 20165:16 pmRNSIssue of Equity - Results of placing
9th Dec 201611:46 amRNSProposed Placing
1st Dec 201612:40 pmRNSPublication of a Supplementary Prospectus
18th Nov 20169:54 amRNSMonthly Update - October 2016
14th Nov 20162:55 pmRNSNet Asset Value(s) - October 2016
10th Nov 20165:20 pmRNSDividend Declaration-Period End 30 September 2016
25th Oct 201612:15 pmRNSNet Asset Value - Change to NAV calculation basis
14th Oct 20161:20 pmRNSNet Asset Value(s) - September 2016
30th Sep 20163:18 pmRNSMonthly Update - August 2016
14th Sep 20163:04 pmRNSNet Asset Value(s) - August 2016
30th Aug 20166:06 pmRNSHalf-year Report
26th Aug 20163:29 pmRNSHalf-year Report
26th Aug 20163:19 pmRNSDividend Declaration
25th Aug 20165:42 pmRNSMonthly Update - July 2016
12th Aug 20164:56 pmRNSNet Asset Value(s) - July 2016
15th Jul 20163:15 pmRNSNet Asset Value - June 2016 replacement of 3538E
15th Jul 20162:18 pmRNSPortfolio Update - June 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.